Jun 23, 2026 08:00AM
Jun 23, 2026 08:00AM
May 5, 2026 04:01PM
Apr 2, 2026 12:00PM
Apr 2, 2026 10:46AM
Apr 2, 2026 08:31AM
Apr 2, 2026 08:30AM Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Mar 30, 2026 08:32AM
Mar 30, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 18, 2026 06:44AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Jan 30, 2026 08:31AM
Jan 30, 2026 08:30AM
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Dec 30, 2025 04:06PM
Dec 30, 2025 04:05PM
Dec 30, 2025 04:58AM Ultragenyx Pharma (RARE) PT Lowered to $45 at Wells Fargo
Dec 30, 2025 02:03AM
Dec 29, 2025 01:50PM
Dec 29, 2025 08:30AM
Dec 29, 2025 08:30AM
Nov 4, 2025 04:05PM
Oct 30, 2025 08:00AM
Sep 8, 2025 04:05PM Ultragenyx reports positive 96-week data for GSDIa gene therapy DTX401
Sep 8, 2025 04:05PM
Aug 18, 2025 08:06AM
Aug 18, 2025 08:00AM
Aug 5, 2025 04:01PM
Jul 31, 2025 04:05PM
Jul 31, 2025 04:05PM
Jul 14, 2025 08:01AM Health Canada approves Evkeeza for infants as young as 6 months with HoFH
Jul 14, 2025 08:00AM
Jul 11, 2025 05:05PM
Jul 11, 2025 04:30PM
Jul 11, 2025 04:30PM
Jul 9, 2025 04:05PM
Jul 9, 2025 04:05PM
Jun 27, 2025 08:00AM Ultragenyx Pharma (RARE) Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
Jun 27, 2025 08:00AM
May 6, 2025 04:01PM
Feb 19, 2025 07:13AM
Feb 18, 2025 08:07AM
Feb 18, 2025 08:00AM
Feb 13, 2025 04:01PM
Feb 5, 2025 08:00AM Ultragenyx Pharma (RARE) Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with San
Feb 5, 2025 08:00AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All